| 1. |
邵海琳. 糖尿病視網膜病變的早期防治[J]. 開卷有益(求醫問藥), 2023, 21(11): 18.Shao HL. Early prevention and treatment of diabetic retinopathy[J]. Journal for Beneficial Readings Drug Information & Medical Advices, 2023, 21(11): 18.
|
| 2. |
中華醫學會眼科學分會眼底病學組, 中國醫師協會眼科醫師分會眼底病學組. 我國糖尿病視網膜病變臨床診療指南(2022年)[J]. 中華眼底病雜志, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.Fundus Pathology Group, Ophthalmology Branch, Chinese Medical Association, Ophthalmology Branch, Chinese Medical Doctor Association. Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)[J]. Chin J Ocul Fundus Dis, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.
|
| 3. |
中國研究型醫院學會糖尿病學專業委員會. 社區醫療機構糖尿病視網膜病變篩查工作流程與管理規范的專家共識(2023版)[J]. 中華糖尿病雜志, 2024, 16(1): 20-27. DOI: 10.3760/cma.j.cn115791-20231010-00229.Diabetology Committee of Chinese Society of Research Hospitals. Expert consensus on workflow and management of screening for diabetic retinopathy in primary healthcare institutions (2023 edition)[J]. Chin J Diabetes Mellitus, 2024, 16(1): 20-27. DOI: 10.3760/cma.j.cn115791-20231010-00229.
|
| 4. |
中國醫師協會內分泌代謝科醫師分會, 國家代謝性疾病臨床醫學研究中心. 糖尿病分型診斷中國專家共識[J]. 中華糖尿病雜志, 2022, 14(2): 120-139. DOI: 10.3760/cma.j.cn115791-20211219-00672.Branch of Endocrinology and Metabolism, Chinese Medical Doctor Association, National Clinical Medical Research Center for Metabolic Diseases. Classification of diabetes mellitus in China: an expert consensus statement[J]. Chin J Diabetes Mellitus, 2022, 14(2): 120-139. DOI: 10.3760/cma.j.cn115791-20211219-00672.
|
| 5. |
Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern?[J]. Ophthalmology, 2020, 127(1): 66-145. DOI: 10.1016/j.ophtha.2019.09.025.
|
| 6. |
Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis[J/OL]. Lancet Glob Health, 2017, 5(9): e888-e897[2017-08-02]. https://pubmed.ncbi.nlm.nih.gov/28779882/. DOI: 10.1016/s2214-109x(17)30293-0.
|
| 7. |
王文. 對2009年基層版《中國高血壓防治指南》的解讀[J]. 內科急危重癥雜志, 2010, 16(3): 116-119. DOI: 10.3969/j.issn.1007-1024.2010.03.002.Wang W. Interpretation for basic level edition of China guideline for prevention and treatment of hypertension 2009[J]. Journal of Internal Intensive Medicine, 2010, 16(3): 116-119. DOI: 10.3969/j.issn.1007-1024.2010.03.002.
|
| 8. |
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004, 363(9403): 157-163. DOI: 10.1016/s0140-6736(03)15268-3.
|
| 9. |
洪豆豆, 權金星, 田利民, 等. 甘肅省平原風沙與黃土丘陵地區糖尿病視網膜病變患病率調查[J]. 中國糖尿病雜志, 2023, 31(10): 721-725. DOI: 10.3969/j.issn.1006-6187.2023.10.001.Hong DD, Kwon JX, Tian LM, et al. Epidemiological investigation and analysis of diabetic retinopathy in windy desert area and loess hilly area of Gansu Province[J]. Chin J Diabetes, 2023, 31(10): 721-725. DOI: 10.3969/j.issn.1006-6187.2023.10.001.
|
| 10. |
廖季云, 程時富, 查蕾蕾, 等. 閬中市農村地區2型糖尿病視網膜病變的流行特征及危險因素分析[J]. 解放軍預防醫學雜志, 2020, 38(9): 114-116.Liao JY, Cheng SF, Zha LL, et al. Epidemic characteristics and risk factors of type 2 diabetic retinopathy in rural area of Langzhong city[J]. J Prev Med Chin PLA, 2020, 38(9): 114-116.
|
| 11. |
高胡進, 覃小芳. Ⅱ型糖尿病性視網膜病變患者不良生活方式調查及其對發病率的影響研究[J]. 實用防盲技術, 2022, 17(2): 80-82. DOI: 10.3969/j.issn.1673-3835.2022.02.010.Gao HJ, Qin XF. Investigation of unhealthy lifestyle and its impact on incidence rate of type Ⅱ diabetic retinopathy[J]. Journal of Practical Preventing Blind, 2022, 17(2): 80-82. DOI: 10.3969/j.issn.1673-3835.2022.02.010.
|
| 12. |
陳雪珍, 吳慧華, 劉媛媛, 等. 糖尿病視網膜病變患病率的meta分析[J]. 中國公共衛生管理, 2020, 36(4): 460-465. DOI: 10.19568/j.cnki.23-1318.2020.04.006.Chen XZ, Wu HH, Liu YY, et al. A meta-analysis of prevalence rate of diabetic retinopathy[J]. Chinese Journal of Public Health Management, 2020, 36(4): 460-465. DOI: 10.19568/j.cnki.23-1318.2020.04.006.
|
| 13. |
黃曉波, 張培, 林森林, 等. 2016-2018年上海市新涇社區糖尿病眼病干預效果分析[J]. 中華預防醫學雜志, 2022, 56(1): 44-48. DOI: 10.3760/cma.j.cn112150-20211128-01094.Huang XB, Zhang P, Lin SL, et al. Analysis of community intervention effects for diabetic eye diseases in Shanghai Xinjing community from 2016 to 2018[J]. Chin J Prev Med, 2022, 56(1): 44-48. DOI: 10.3760/cma.j.cn112150-20211128-01094.
|
| 14. |
彭慧, 楊飛飛, 薛俊磊, 等. 上海市嘉定區2型糖尿病患者視網膜病變篩查結果分析[J]. 中國初級衛生保健, 2024, 38(4): 40-43. DOI: 10.3969/j.issn.1001-568X.2024.04.0010.Peng H, Yang FF, Xue JL, et al. Analysis of screening results of retinopathy in type 2 diabetic patients in Jiading distinct of Shanghai[J]. Chinese Primary Health Care, 2024, 38(4): 40-43. DOI: 10.3969/j.issn.1001-568X.2024.04.0010.
|
| 15. |
蔡文瑤, 楊麗輝, 阿米娜. 2型糖尿病患者發生糖尿病視網膜病變的危險因素分析[J]. 西藏醫藥, 2023, 44(2): 68-70.Cai WY, Yang LH, Amina. Risk factors of diabetic retinopathy in patients with type 2 diabetes mellitus[J]. Tibetan Medical Journal, 2023, 44(2): 68-70.
|
| 16. |
盧佳琦, 李帥, 馬桂巧, 等. 糖尿病視網膜病變相關危險因素分析及預測模型研究[J]. 實用藥物與臨床, 2023, 26(6): 504-508. DOI: 10.14053/j.cnki.ppcr.202306005.Lu JQ , Li S, Ma GQ, et al. Analysis of risk factors associated with diabetic retinopathy and the study on the model of prediction[J]. Practical Pharmacy And Clinical Remedies, 2023, 26(6): 504-508. DOI: 10.14053/j.cnki.ppcr.202306005.
|
| 17. |
薛朔, 毛一凡, 王春芳. 糖尿病視網膜病變危險因素的研究進展[J]. 安徽醫藥, 2023, 27(5): 863-867. DOI: 10.3969/j.issn.1009-6469.2023.05.004.Xue S, Mao YF, Wang CF. Research progress on risk factors of diabetic retinopathy[J]. Anhui Medical and Pharmaceutical Journal, 2023, 27(5): 863-867. DOI: 10.3969/j.issn.1009-6469.2023.05.004.
|
| 18. |
賴麗平, 劉賀, 黃錫嵐, 等. 2型糖尿病患者的糖尿病視網膜病變患病率及危險因素[J]. 廣西醫學, 2022, 44(4): 370-375. DOI: 10.11675/j.issn.0253-4304.2022.04.03.Lai LP, Liu H, Huang XL, et al. Prevalence rate of and risk factors for diabetic retinopathy in patients with type 2 diabetes mellitus[J]. Guangxi Medical Journal, 2022, 44(4): 370-375. DOI: 10.11675/j.issn.0253-4304.2022.04.03.
|
| 19. |
Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35(3): 556-564. DOI: 10.2337/dc11-1909.
|
| 20. |
高瑋, 買買提熱夏提·玉蘇甫, 卡麗比努爾·艾爾肯, 等. 血清微量元素佐助臨床特征預測2型糖尿病性視網膜病變發病風險的價值及模型構建[J]. 川北醫學院學報, 2022, 37(1): 51-54. DOI: 10.3969/j.issn.1005-3697.2022.01.012.Gao W, Maimaitirexiati·YSF, Karibinur·EIK. Value analysis and model construction of serum trace element assisted clinical features in predicting the risk of type 2 diabetic retinopathy[J]. Journal of North Sichuan Medical College, 2022, 37(1): 51-54. DOI: 10.3969/j.issn.1005-3697.2022.01.012.
|
| 21. |
萬文萃, 龍洋. 糖尿病視網膜病變的流行病學、病因學與發病機制研究現狀[J]. 眼科新進展, 2022, 42(9): 673-679. DOI: 10.13389/j.cnki.rao.2022.0138.Wan WC, Long Y. Research status of epidemiology, etiology and pathogenesis of diabetic retinopathy[J]. Rec Adv Ophthalmol, 2022, 42(9): 673-679. DOI: 10.13389/j.cnki.rao.2022.0138.
|
| 22. |
肖子軒, 白桂榮, 賀艷婷, 等. 寧夏社區2型糖尿病患者血脂異常情況及影響因素分析[J]. 中國慢性病預防與控制, 2021, 29(5): 382-386. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.05.014.Xiao ZX, Bai GR, He YT, et al. Analysis of dyslipidemia and its influencing factors in type 2 diabetes patients in Ningxia community[J]. Chinese Journal of Prevention and Control of Chronic Diseases, 2021, 29(5): 382-386. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.05.014.
|
| 23. |
龔瑩瑩, 劉青, 邱威, 等. 糖尿病患者視網膜病變危險因素分析及其對眼前段生物學結構的影響[J]. 國際眼科雜志, 2020, 20(7): 1216-1221. DOI: 10.3980/j.issn.1672-5123.2020.7.22.Gong YY, Liu Q, Qiu W, et al. Analysis of the related risk factors of diabetic retinopathy and changes of biological structures of anterior segment in diabetic patients[J]. Int Eye Sci, 2020, 20(7): 1216-1221. DOI: 10.3980/j.issn.1672-5123.2020.7.22.
|
| 24. |
王金瑞, 楊瑩. 2型糖尿病視網膜病變相關因素研究進展[J]. 昆明醫科大學學報, 2019, 40(4): 131-135. DOI: 10.3969/j.issn.1003-4706.2019.04.027.Wang JR, Yang Y. Research progress of related factors of type 2 diabetic retinopathy[J]. Journal of Kunming Medical University, 2019, 40(4): 131-135. DOI: 10.3969/j.issn.1003-4706.2019.04.027.
|
| 25. |
李瑩, 董哲毅, 王倩, 等. 2型糖尿病合并不同病理分型腎病的眼底表現[J]. 解放軍醫學院學報, 2022, 43(10): 1031-1035. DOI: 10.3969/j.issn.2095-5227.2022.10.006.Li Y, Dong ZY, Wang Q, et al. Fundus manifestations of different types of nephropathy in type 2 diabetes mellitu[J]. Acad J Chin PLA Med Sch, 2022, 43(10): 1031-1035. DOI: 10.3969/j.issn.2095-5227.2022.10.006.
|
| 26. |
Sabanayagam C, Sultana R, Banu R, et al. Association between body mass index and diabetic retinopathy in Asians: the Asian Eye Epidemiology Consortium (AEEC) study[J]. Br J Ophthalmol, 2022, 106(7): 980-986. DOI: 10.1136/bjophthalmol-2020-318208.
|